TWiV 947: Clinical update with Dr. Daniel Griffin
b'
In his weekly clinical update Dr. Griffin discusses the\\xa0prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic, severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters, and how\\xa0successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials.
Subscribe (free):\\xa0Apple Podcasts,\\xa0Google Podcasts,\\xa0RSS,\\xa0email
Become a\\xa0patron\\xa0of\\xa0TWiV!
Links for this episode
- Support MicrobeTV with a Spike t-shirt at Vaccinated.US
- Prediction of upcoming\\xa0global infection burden\\xa0of Influenza (The LANCET)
- Severe\\xa0COVID-19 outcomes\\xa0after full vaccination (The LANCET)
- Successful immunomodulators\\xa0for treatment of COVID-19 (CMI)
- Remdesivir fact sheet\\xa0for providers (Veklury)\\xa0
- Bebtelovimab fact sheet\\xa0for providers (FDA)
- PAXLOVID patient eligibility\\xa0screening checklist (FDA)
- Dr. Griffin\\u2019s treatment guide (pdf)
- Contribute to\\xa0Floating Doctors fundraiser at PWB
- Letters read\\xa0on TWiV 947
- Timestamps by Jolene. Thanks!
Intro music is by\\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv